New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
'White matter lesion' mapping tool identifies early signs of dementia

'White matter lesion' mapping tool identifies early signs of dementia

by NYU Langone HealthCaption: MRI image of human brain shows multiple bright spots (white matter hyperintensities) in centerCourtesy of Elsevier/Academic Radiology. Credit: Elsevier/Academic Radi
Neurology April 25,2024
'White matter lesion' mapping tool identifies early signs of dementia

'White matter lesion' mapping tool identifies early signs of dementia

by NYU Langone HealthCaption: MRI image of human brain shows multiple bright spots (white matter hyperintensities) in centerCourtesy of Elsevier/Academic Radiology. Credit: Elsevier/Academic Radi
Neurology April 25,2024
Early diagnosis and treatment of Alzheimer's disease by targeting toxic soluble Aβ oligomers

Early diagnosis and treatment of Alzheimer's disease by targeting toxic soluble Aβ oligomers

by Bar-Ilan University(A) Potential influence of azaGly residue on hydrogen-bonding of cyclic D,L-α-hexapeptide nanotubes which share common cross β-sheet structures with (B) Aβ. For clarity, all
Neurology April 25,2024
Early diagnosis and treatment of Alzheimer's disease by targeting toxic soluble Aβ oligomers

Early diagnosis and treatment of Alzheimer's disease by targeting toxic soluble Aβ oligomers

by Bar-Ilan University(A) Potential influence of azaGly residue on hydrogen-bonding of cyclic D,L-α-hexapeptide nanotubes which share common cross β-sheet structures with (B) Aβ. For clarity, all
Neurology April 25,2024
Controversial Alzheimer's drug should not be approved out of desperation, warn Aussie experts

Controversial Alzheimer's drug should not be approved out of desperation, warn Aussie experts

by Medical Journal of AustraliaCredit: Unsplash/CC0 Public DomainAducanumab, a controversial Alzheimer's disease medication with "questionable efficacy," is under review by the Therapeut
Neurology April 25,2024
Controversial Alzheimer's drug should not be approved out of desperation, warn Aussie experts

Controversial Alzheimer's drug should not be approved out of desperation, warn Aussie experts

by Medical Journal of AustraliaCredit: Unsplash/CC0 Public DomainAducanumab, a controversial Alzheimer's disease medication with "questionable efficacy," is under review by the Therapeut
Neurology April 25,2024
Cancer chemotherapy drug reverses Alzheimer's symptoms in mice

Cancer chemotherapy drug reverses Alzheimer's symptoms in mice

by University of British ColumbiaCredit: Pixabay/CC0 Public DomainA drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's d
Neurology April 25,2024
Cancer chemotherapy drug reverses Alzheimer's symptoms in mice

Cancer chemotherapy drug reverses Alzheimer's symptoms in mice

by University of British ColumbiaCredit: Pixabay/CC0 Public DomainA drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's d
Neurology April 25,2024
Biogen cuts the price tag on its Alzheimer's drug in half

Biogen cuts the price tag on its Alzheimer's drug in half

by Tom MurphyThe Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Biogen is slashing the price of its Alzheimer's treatment months after the drug debuted to widespread critic
Neurology April 25,2024
Biogen cuts the price tag on its Alzheimer's drug in half

Biogen cuts the price tag on its Alzheimer's drug in half

by Tom MurphyThe Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Biogen is slashing the price of its Alzheimer's treatment months after the drug debuted to widespread critic
Neurology April 25,2024
Dementia rates fall in Australia ahead of expected surge

Dementia rates fall in Australia ahead of expected surge

by University of AdelaideCredit: CC0 Public DomainDementia rates among older Australians are falling, sparking suggestions that measures aimed at improving the physical health of older people may
Neurology April 25,2024
Dementia rates fall in Australia ahead of expected surge

Dementia rates fall in Australia ahead of expected surge

by University of AdelaideCredit: CC0 Public DomainDementia rates among older Australians are falling, sparking suggestions that measures aimed at improving the physical health of older people may
Neurology April 25,2024
Alzheimer's may strike women and men in different ways

Alzheimer's may strike women and men in different ways

by Steven Reinberg Healthday Reporter(HealthDay)—The ravages of Alzheimer's may strike later in women than men, but once it takes hold women tend to deteriorate far faster than men, according to a
Neurology April 25,2024
Alzheimer's may strike women and men in different ways

Alzheimer's may strike women and men in different ways

by Steven Reinberg Healthday Reporter(HealthDay)—The ravages of Alzheimer's may strike later in women than men, but once it takes hold women tend to deteriorate far faster than men, according to a
Neurology April 25,2024
Helping dementia patients recall grandchildren's names

Helping dementia patients recall grandchildren's names

by Northwestern UniversityCredit: CC0 Public DomainA novel telemedicine speech therapy program for people with language problems due to dementia significantly improved their ability to recall wor
Neurology April 25,2024
Helping dementia patients recall grandchildren's names

Helping dementia patients recall grandchildren's names

by Northwestern UniversityCredit: CC0 Public DomainA novel telemedicine speech therapy program for people with language problems due to dementia significantly improved their ability to recall wor
Neurology April 25,2024
Targeting the LANDO pathway holds a potential clue to treating Alzheimer's disease

Targeting the LANDO pathway holds a potential clue to treating Alzheimer's disease

by St. Jude Children's Research HospitalBradlee Heckmann, Ph.D., of St. Jude Immunology. Credit: St. Jude Children's Research HospitalScientists at St. Jude Children's Research Hospit
Neurology April 25,2024
Targeting the LANDO pathway holds a potential clue to treating Alzheimer's disease

Targeting the LANDO pathway holds a potential clue to treating Alzheimer's disease

by St. Jude Children's Research HospitalBradlee Heckmann, Ph.D., of St. Jude Immunology. Credit: St. Jude Children's Research HospitalScientists at St. Jude Children's Research Hospit
Neurology April 25,2024
The music therapy that helped Gabby Giffords speak again is getting dementia patients moving

The music therapy that helped Gabby Giffords speak again is getting dementia patients moving

by Stacey BurlingCredit: CC0 Public DomainMany of us know of music therapy as a way to soothe the troubled and stressed or to activate memories of favorite songs embedded deeply in the minds of people
Neurology April 25,2024
The music therapy that helped Gabby Giffords speak again is getting dementia patients moving

The music therapy that helped Gabby Giffords speak again is getting dementia patients moving

by Stacey BurlingCredit: CC0 Public DomainMany of us know of music therapy as a way to soothe the troubled and stressed or to activate memories of favorite songs embedded deeply in the minds of people
Neurology April 25,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com